On December 3, 2025 Exelixis, Inc. (Nasdaq: EXEL) reported that it will webcast its virtual event, Exelixis 2025 R&D Day: Building Next-generation Oncology Franchises, on Wednesday, December 10, 2025, from 1:00 p.m. to 3:30 p.m. EST. During the event, featured speakers will review the progress of Exelixis’ R&D activities and outline the company’s strategy to advance future oncology franchises. These efforts underscore Exelixis’ continued focus on raising standards of care, helping more patients with cancer and generating long-term value for shareholders.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live webcast and a recording of the event will be available at EXELRDDay.com, as well as www.exelixis.com on the Event Calendar page under the Investors & News heading, where the content will remain accessible for one year. To register and access the webcast, please use the registration code: EXELR&D. Participants are encouraged to register in advance to ensure timely access on the day of the event.

(Press release, Exelixis, DEC 3, 2025, View Source [SID1234661101])